A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease
The activities of two new macrolides, azithromycin and clarithromycin, were compared in an aerosol-infected guinea-pig model of legionnaires' disease. The results of this study indicate that a low oral dose of azithromycin (3.6 mg/kg) administered once daily gives 100% survival in Legionella pn...
Gespeichert in:
Veröffentlicht in: | Journal of antimicrobial chemotherapy 1993-06, Vol.31 (suppl-E), p.171-176 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 176 |
---|---|
container_issue | suppl-E |
container_start_page | 171 |
container_title | Journal of antimicrobial chemotherapy |
container_volume | 31 |
creator | Fitzgeorge, R. B. Lever, S. Baskerville, A. |
description | The activities of two new macrolides, azithromycin and clarithromycin, were compared in an aerosol-infected guinea-pig model of legionnaires' disease. The results of this study indicate that a low oral dose of azithromycin (3.6 mg/kg) administered once daily gives 100% survival in Legionella pneumophila-infected animals. An eight-fold higher dose of clarithromycin (28.8mg/kg) given twice-daily was required to achieve the same effect. Similarly, azithromycin was more effective than clarithromycin in preventing pyrexia and in reducing numbers of bacteria and lesions in the lung. |
doi_str_mv | 10.1093/jac/31.suppl_E.171 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75929471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75929471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-8e38a6b9cafc3d139fc79d1b7615660fab920786d17a1d1dad6afeda5caaf20a3</originalsourceid><addsrcrecordid>eNpFUN9rFDEQDmKpZ_UfEIR90qe9Zja3yeaxLa0nFKxUQXwJs8nEpu5u1mQPen3wb3evd1QYGOb7BfMx9g74ErgWp_doTwUs82YcO3O5BAUv2AJWkpcV1_CSLbjgdalWtXjFXud8zzmXtWyO2XEjtOSaL9jfs8LGfsQUchyK6IvpjgryPli0292Nj2G6S7Hf2jAUOLjCdrP4PzRPTNjtfAnHJws9jJRCT8M04xhSG9NARUe_QhyG-ab8sXAhE2Z6w448dpneHvYJ-351-e1iXV5_-fT54uy6tELIqWxINChbbdFb4UBob5V20CoJtZTcY6srrhrpQCE4cOgkenJYW0RfcRQn7MM-d0zxz4byZPqQLXUdDhQ32ahaV3qlYBZWe6FNMedE3ozzK5i2BrjZlW7m0o0AcyjdwJPp_SF90_bkni2Hlme-3PMhT_TwTGP6baQSqjbrHz_N12bNb2_Pz82N-AcfkpOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75929471</pqid></control><display><type>article</type><title>A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease</title><source>Oxford University Press Journals Digital Archive legacy</source><source>MEDLINE</source><creator>Fitzgeorge, R. B. ; Lever, S. ; Baskerville, A.</creator><creatorcontrib>Fitzgeorge, R. B. ; Lever, S. ; Baskerville, A.</creatorcontrib><description>The activities of two new macrolides, azithromycin and clarithromycin, were compared in an aerosol-infected guinea-pig model of legionnaires' disease. The results of this study indicate that a low oral dose of azithromycin (3.6 mg/kg) administered once daily gives 100% survival in Legionella pneumophila-infected animals. An eight-fold higher dose of clarithromycin (28.8mg/kg) given twice-daily was required to achieve the same effect. Similarly, azithromycin was more effective than clarithromycin in preventing pyrexia and in reducing numbers of bacteria and lesions in the lung.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/31.suppl_E.171</identifier><identifier>PMID: 8396090</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Administration, Inhalation ; Administration, Oral ; Aerosols ; Animals ; Azithromycin ; Clarithromycin - pharmacology ; Disease Models, Animal ; Erythromycin - analogs & derivatives ; Erythromycin - pharmacology ; Female ; Guinea Pigs ; Legionella pneumophila ; Legionnaires' Disease - drug therapy ; Legionnaires' Disease - microbiology ; Legionnaires' Disease - pathology ; Lung - microbiology ; Lung - pathology</subject><ispartof>Journal of antimicrobial chemotherapy, 1993-06, Vol.31 (suppl-E), p.171-176</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-8e38a6b9cafc3d139fc79d1b7615660fab920786d17a1d1dad6afeda5caaf20a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8396090$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fitzgeorge, R. B.</creatorcontrib><creatorcontrib>Lever, S.</creatorcontrib><creatorcontrib>Baskerville, A.</creatorcontrib><title>A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The activities of two new macrolides, azithromycin and clarithromycin, were compared in an aerosol-infected guinea-pig model of legionnaires' disease. The results of this study indicate that a low oral dose of azithromycin (3.6 mg/kg) administered once daily gives 100% survival in Legionella pneumophila-infected animals. An eight-fold higher dose of clarithromycin (28.8mg/kg) given twice-daily was required to achieve the same effect. Similarly, azithromycin was more effective than clarithromycin in preventing pyrexia and in reducing numbers of bacteria and lesions in the lung.</description><subject>Administration, Inhalation</subject><subject>Administration, Oral</subject><subject>Aerosols</subject><subject>Animals</subject><subject>Azithromycin</subject><subject>Clarithromycin - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Erythromycin - analogs & derivatives</subject><subject>Erythromycin - pharmacology</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>Legionella pneumophila</subject><subject>Legionnaires' Disease - drug therapy</subject><subject>Legionnaires' Disease - microbiology</subject><subject>Legionnaires' Disease - pathology</subject><subject>Lung - microbiology</subject><subject>Lung - pathology</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUN9rFDEQDmKpZ_UfEIR90qe9Zja3yeaxLa0nFKxUQXwJs8nEpu5u1mQPen3wb3evd1QYGOb7BfMx9g74ErgWp_doTwUs82YcO3O5BAUv2AJWkpcV1_CSLbjgdalWtXjFXud8zzmXtWyO2XEjtOSaL9jfs8LGfsQUchyK6IvpjgryPli0292Nj2G6S7Hf2jAUOLjCdrP4PzRPTNjtfAnHJws9jJRCT8M04xhSG9NARUe_QhyG-ab8sXAhE2Z6w448dpneHvYJ-351-e1iXV5_-fT54uy6tELIqWxINChbbdFb4UBob5V20CoJtZTcY6srrhrpQCE4cOgkenJYW0RfcRQn7MM-d0zxz4byZPqQLXUdDhQ32ahaV3qlYBZWe6FNMedE3ozzK5i2BrjZlW7m0o0AcyjdwJPp_SF90_bkni2Hlme-3PMhT_TwTGP6baQSqjbrHz_N12bNb2_Pz82N-AcfkpOg</recordid><startdate>19930601</startdate><enddate>19930601</enddate><creator>Fitzgeorge, R. B.</creator><creator>Lever, S.</creator><creator>Baskerville, A.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930601</creationdate><title>A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease</title><author>Fitzgeorge, R. B. ; Lever, S. ; Baskerville, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-8e38a6b9cafc3d139fc79d1b7615660fab920786d17a1d1dad6afeda5caaf20a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Administration, Inhalation</topic><topic>Administration, Oral</topic><topic>Aerosols</topic><topic>Animals</topic><topic>Azithromycin</topic><topic>Clarithromycin - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Erythromycin - analogs & derivatives</topic><topic>Erythromycin - pharmacology</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>Legionella pneumophila</topic><topic>Legionnaires' Disease - drug therapy</topic><topic>Legionnaires' Disease - microbiology</topic><topic>Legionnaires' Disease - pathology</topic><topic>Lung - microbiology</topic><topic>Lung - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fitzgeorge, R. B.</creatorcontrib><creatorcontrib>Lever, S.</creatorcontrib><creatorcontrib>Baskerville, A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fitzgeorge, R. B.</au><au>Lever, S.</au><au>Baskerville, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1993-06-01</date><risdate>1993</risdate><volume>31</volume><issue>suppl-E</issue><spage>171</spage><epage>176</epage><pages>171-176</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><abstract>The activities of two new macrolides, azithromycin and clarithromycin, were compared in an aerosol-infected guinea-pig model of legionnaires' disease. The results of this study indicate that a low oral dose of azithromycin (3.6 mg/kg) administered once daily gives 100% survival in Legionella pneumophila-infected animals. An eight-fold higher dose of clarithromycin (28.8mg/kg) given twice-daily was required to achieve the same effect. Similarly, azithromycin was more effective than clarithromycin in preventing pyrexia and in reducing numbers of bacteria and lesions in the lung.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>8396090</pmid><doi>10.1093/jac/31.suppl_E.171</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-7453 |
ispartof | Journal of antimicrobial chemotherapy, 1993-06, Vol.31 (suppl-E), p.171-176 |
issn | 0305-7453 1460-2091 |
language | eng |
recordid | cdi_proquest_miscellaneous_75929471 |
source | Oxford University Press Journals Digital Archive legacy; MEDLINE |
subjects | Administration, Inhalation Administration, Oral Aerosols Animals Azithromycin Clarithromycin - pharmacology Disease Models, Animal Erythromycin - analogs & derivatives Erythromycin - pharmacology Female Guinea Pigs Legionella pneumophila Legionnaires' Disease - drug therapy Legionnaires' Disease - microbiology Legionnaires' Disease - pathology Lung - microbiology Lung - pathology |
title | A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A40%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20the%20efficacy%20of%20azithromycin%20and%20clarithromycin%20in%20oral%20therapy%20of%20experimental%20airborne%20legionnaires'%20disease&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Fitzgeorge,%20R.%20B.&rft.date=1993-06-01&rft.volume=31&rft.issue=suppl-E&rft.spage=171&rft.epage=176&rft.pages=171-176&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/31.suppl_E.171&rft_dat=%3Cproquest_cross%3E75929471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75929471&rft_id=info:pmid/8396090&rfr_iscdi=true |